Cowen and Company’s Insmed INSM Stock Holding History

Cowen and Company’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,440	Closed	-$393K	–	670
2021 Q4	$393K	Buy	+14,440	New	+$413K	0.04%	249

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cowen and Company's INSM Position: Q1 2022 in Review

Cowen and Company sold out of Insmed (INSM) in Q1 2022, closing a stake of 14,440 shares — an estimated $393K sold.

Cowen and Company first reported a position in INSM in Q4 2021 and held it in 1 quarter. The position peaked at $393K in Q4 2021. 224 funds tracked by Wall St. Rank hold INSM as of Q1 2022.

Cowen and Company reported no remaining Insmed position as of Q1 2022 after selling out during the quarter.
Cowen and Company sold 14,440 Insmed shares in Q1 2022, an estimated $393K.
Cowen and Company first reported a position in Insmed in Q4 2021 and held it in 1 quarter.
Cowen and Company's Insmed position peaked at $393K in Q4 2021.
224 funds tracked by Wall St. Rank held Insmed as of Q1 2022.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.